Frank van de Veerdonk
Overview
Explore the profile of Frank van de Veerdonk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
1634
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vorsteveld E, van der Made C, Smeekens S, Schuurs-Hoeijmakers J, Astuti G, Diepstra H, et al.
Clin Immunol
. 2024 Oct;
268:110375.
PMID: 39369972
While next generation sequencing has expanded the scientific understanding of Inborn Errors of Immunity (IEI), the clinical use and re-use of exome sequencing is still emerging. We revisited clinical exome...
2.
Roring R, Li W, Liu R, Bruno M, Zhang B, Debisarun P, et al.
iScience
. 2024 Mar;
27(4):109356.
PMID: 38510149
Familial Mediterranean fever (FMF) is a periodic fever syndrome caused by variation in . FMF is known for IL-1β dysregulation, but the innate immune landscape of this disease has not...
3.
Marouane A, Neveling K, Deden A, van den Heuvel S, Zafeiropoulou D, Castelein S, et al.
Front Genet
. 2024 Jan;
14:1304520.
PMID: 38259611
Rapid exome sequencing (rES) has become the first-choice genetic test for critically ill patients, mostly neonates, young infants, or fetuses in prenatal care, in time-sensitive situations and when it is...
4.
Hills T, Lorenzi E, Berry L, Shyamsundar M, Al-Beidh F, Annane D, et al.
N Engl J Med
. 2023 Oct;
389(25):2341-2354.
PMID: 37888913
Background: The efficacy of simvastatin in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear. Methods: In an ongoing international, multifactorial, adaptive platform, randomized, controlled trial, we evaluated simvastatin...
5.
de Figueiredo A, Dos Santos J, Kischkel B, Ardiansyah E, Oosting M, Guimaraes Matos G, et al.
J Fungi (Basel)
. 2023 Apr;
9(4).
PMID: 37108883
Paracoccidioidomycosis (PCM) is a systemic mycosis caused by fungi of the genus and the different clinical forms of the disease are associated with the host immune responses. Quantitative trait loci...
6.
Rosati D, Bruno M, van de Veerdonk F, Ten Oever J, Meis J, Netea M
Med Mycol
. 2022 Oct;
60(10).
PMID: 36195329
Candida africana is a fungal pathogen that rarely causes invasive infections, but is mainly isolated from patients with vaginal infections. Vulvovaginal candidiasis is associated with dysregulated inflammatory responses of the...
7.
Liu Z, Kilic G, Li W, Bulut O, Gupta M, Zhang B, et al.
Front Immunol
. 2022 Apr;
13:838132.
PMID: 35464396
The majority of COVID-19 patients experience mild to moderate disease course and recover within a few weeks. An increasing number of studies characterized the long-term changes in the specific anti-SARS-CoV-2...
8.
van Leeuwen L, GeurtsvanKessel C, Ellerbroek P, de Bree G, Potjewijd J, Rutgers A, et al.
J Allergy Clin Immunol
. 2022 Apr;
149(6):1949-1957.
PMID: 35421449
Background: Patients with inborn errors of immunity (IEI) are at increased risk of severe coronavirus disease-2019 (COVID-19). Effective vaccination against COVID-19 is therefore of great importance in this group, but...
9.
Estcourt L, Turgeon A, McQuilten Z, McVerry B, Al-Beidh F, Annane D, et al.
JAMA
. 2021 Oct;
326(17):1690-1702.
PMID: 34606578
Importance: The evidence for benefit of convalescent plasma for critically ill patients with COVID-19 is inconclusive. Objective: To determine whether convalescent plasma would improve outcomes for critically ill adults with...
10.
Schuurbiers M, Bruno M, Zweijpfenning S, Magis-Escurra C, Boeree M, Netea M, et al.
ERJ Open Res
. 2020 Dec;
6(4).
PMID: 33263065
The prevalence of infections in non-cystic fibrosis (CF) patients has increased in recent years. In this study, we investigate whether immune defects explain the apparent susceptibility to this opportunistic infection...